Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate the effects of treatment for specific language deficits in people with aphasia. In addition to language and cognitive measures, changes in brain function wi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Northwestern University
Collaborators
NCT07036406 · Aphasia, Aphasia Following Cerebral Infarction, and more
NCT05653440 · Aphasia, Stroke
NCT04682223 · Aphasia, Stroke, and more
NCT06739967 · Primary Progressive Aphasia(PPA)
NCT04715399 · Frontotemporal Degeneration(FTD), Primary Progressive Aphasia(PPA), and more
Northwestern University
Chicago, Illinois
Johns Hopkins University
Baltimore, Maryland
Boston University
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions